MMB-103

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameMMB-103

Drug Alias NameTreg modulator 3 (MediMab Biotherapeutics)immune checkpoint inhibitor 3 (MediMab Biotherapeutics)immune checkpoint antibody 3 (MediMab Biotherapeutics)MMB-103

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionT lymphocytes stimulantsRegulatory T-lymphocytes inhibitorsImmunostimulants

TargetsUpdating

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMediMab Biotherapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMediMab Biotherapeutics Ltd

Active IndicationsN/A

Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A